Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 158,143 shares at $80.00 ($12.4M) on 2018-02-12, disclosed to the SEC on 2018-02-13.
Seasonal sale ($12.4M) by Chief Research Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.98 | 71,775 | $5.6M | 45.3% |
| 2 | $77.98 | 71,775 | $5.6M | 45.3% |
| 3 | $80.00 | 14,593 | $1.2M | 9.4% |
| Total | $78.17 avg | 158,143 | $12.4M | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |